ISTA PHARMACEUTICAL (NASDAQ:ISTA)

View All ReportsStreetInsider.com Reports on ISTA

Nov 3, 2009 06:03 PM After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower

Nov 3, 2009 04:38 PM ISTA Pharmaceuticals (ISTA) Tops Q3 EPS by 3c; Guides In-line for FY Revenues

Nov 2, 2009 01:40 PM Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report

Sep 9, 2009 09:34 AM Morning Movers 9/9: ENCO, VVUS, CLZR, WAVX, HITK, ISTA Higher; HNAB, ENWV, UWBK, AVAV, PBY Lower

Sep 9, 2009 07:19 AM ISTA (ISTA) Announces FDA Approval for Bepreve, Results Fro T-Pred Studies

View All Press ReleasesCompany Press Releases on ISTA

Nov 9, 2009 07:30AM ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)

Oct 21, 2009 04:01PM ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting

Oct 20, 2009 12:00PM ISTA Pharmaceuticals to Present at 2009 BIOCOM Investor Conference

Oct 2, 2009 12:15PM ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results

StreetInsider Reports on ISTA by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on ISTA

Oct 1, 2009 10:19 AM The Top 25

Sep 30, 2009 08:14 AM Healthcare Takeover Talk Continues

Sep 10, 2009 08:05 AM Stocks to Watch This Week

Sep 9, 2009 04:29 PM Closing Update for Wednesday, Sept. 9

Aug 26, 2009 04:42 PM ISTA’s Eye Drug Shows Success

View All FilingsSEC Filings on ISTA

Nov 5, 2009 05:26PM Form 10-Q ISTA PHARMACEUTICALS For: Sep 30

Nov 3, 2009 04:06PM Form 8-K ISTA PHARMACEUTICALS For: Nov 03

Comments on recent ISTA articles

ANDREW OLIVER SATCHELL
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report

Barton Hodes
on Aug 5, 2009
at 10:00 PM ISTA This company has wonderful products and will grow revenues painstakingly slowly. The REAL worth of ISTA is its share value to a corporate buyer. My cost basis is < $1 ... I'm holding for what I see as an inevitable buyout. I'm in the business/industry. Their products are unique and their competitors in BIG pharma can't catch up with comparable products for less than they can pay for ISTA. Bart
Article: ISTA Pharma (ISTA) Reports Q2 Results; Raises FY09 Sales Guidance

Comments on ISTA

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?